General Information of DTT (ID: TTMPART)

DTT Name Uracil nucleotide/cysteinyl leukotriene receptor (GPR17) DTT Info
Gene Name GPR17

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
9 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ASN02563583 DMEO3Y4 Discovery agent N.A. Investigative [1]
ASN04421891 DMC82XN Discovery agent N.A. Investigative [1]
ASN04450772 DMKR69T Discovery agent N.A. Investigative [1]
ASN04885796 DMQ0VZ8 Discovery agent N.A. Investigative [1]
ASN06917370 DMA20JP Discovery agent N.A. Investigative [1]
LTC4 DM702WR Discovery agent N.A. Investigative [2]
LTD4 DMIUZX3 Discovery agent N.A. Investigative [2]
LTE4 DMCPB0Q Discovery agent N.A. Investigative [3]
UDP-glucose DMLT4JA Discovery agent N.A. Investigative [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Investigative Drug(s)
Molecule Interaction Atlas

References

1 In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. J Comput Aided Mol Des. 2011 Aug;25(8):743-52.
2 The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 2006 Oct 4;25(19):4615-27.
3 The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One. 2008;3(10):e3579.